Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease: update

Paolo Zeppilli1, Alessandro Biffi2, Michela Cammarano1

  • 1Unit of Sports Medicine, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.

Minerva Medica
|October 22, 2024
PubMed

Insights

The updated 2023 Cardiological Guidelines for Competitive Sports Eligibility provide comprehensive recommendations for athletes with heart disease. These guidelines ensure safe participation in sports by detailing pre-participation screening and eligibility criteria.

Area of Science:

  • Cardiology
  • Sports Medicine

Background:

  • The Italian Society of Sports Cardiology and the Italian Federation of Sports Medicine (FMSI) have updated their 2023 Cardiological Guidelines for Competitive Sports Eligibility.
  • This revision follows the initial 1989 publication, incorporating advancements in cardiology and sports medicine.

Purpose of the Study:

  • To provide a comprehensive and detailed guide for the sports eligibility of athletes with heart disease.
  • To offer current information and recommendations based on the latest scientific evidence.

Main Methods:

  • The guidelines were developed through collaboration between leading Italian Cardiological Scientific Associations.
  • They incorporate updated pre-participation screening protocols and eligibility/disqualification recommendations for competitive athletes with various heart conditions.

Main Results:

  • The 2023 guidelines offer a revised framework for assessing the sports eligibility of athletes with cardiac conditions.
  • This updated resource addresses pre-participation screening and specific recommendations for various heart conditions.

Conclusions:

  • The 2023 Cardiological Guidelines for Competitive Sports Eligibility are a crucial, reliable, and scientifically thorough resource.
  • They serve as an indispensable tool for healthcare professionals managing competitive athletes with heart conditions.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
741
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
1
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
3
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
1